http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5762296-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_630b360599ea5cf4b5bcbc0c6c0a3e2d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00
filingDate 1980-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d9e40ae2de6784c1ce22ee8fdcc4a72
publicationDate 1982-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5762296-A
titleOfInvention Preparation of 17alpha-hydroxyprogesterone derivative
abstract PURPOSE: To obtain the titled compound useful as an intermediate for a luteohormone, etc. industrially and advantageously, by reacting a specific 17β-cyano- 17α-hydroxyandrost-4-en-3-one, etc. with a methyl metallic compound, and hydrolyzing the resultant reaction product. n CONSTITUTION: (A) 17β-Cyano-17α-hydroxyandrost-4-en-3-one or 17β-cyano-17α- hydroxyandrosta-4,9 (11) -dien- 3-one in which the carbonyl group at the 3-position and the hydroxyl group at the 17α-position are protected is reacted with (B) a methyl metallic compound expressed by the formula CH 3 X (X is lithium atom or halomagnesium), e.g. methyl lithium, at -30W+100°C, and the resultant reaction product is then hydrolyzed to give the aimed compound. n COPYRIGHT: (C)1982,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4977255-A
priorityDate 1980-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234224821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426622676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426481040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10859900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3028194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13035453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID169870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57266345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234397439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234224820
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724049

Total number of triples: 31.